Molecular drug-organiser: Synthesis, characterization and biological evaluation of penicillin v and/or nalidixic acid calixarene-based podands

Bioorganic and Medicinal Chemistry

Volumn 19, Issue 24, 2011, Pages 7534-7540

  Ben Salem, Adel ^a,b   Sautrey, Guillaume ^a   Fontanay, Stéphane ^a   Duval, Raphaël E ^a   Regnouf De Vains, Jean Bernard ^a  

^a NANCY UNIVERSITÉ   (France)

^b Faculté des Sciences de Sfax   (Tunisia)

Author keywords

Antibacterial; Calixarene; DMSO; Nalidixic acid; Penicillin; Prodrug

Indexed keywords

5,11,17,23 TETRA (TERT BUTYL) 25 (3 BROMOPROPYLOXY) 26,27,28 TRIHYDROXYCALIX[4]ARENE; 5,11,17,23 TETRA (TERT BUTYL) 25 (3 BROMOPROPYLOXY) 27 (3 NALIDIXOPROPYLOXY) 26,28 DIHYDROXYCALIX[4]ARENE; 5,11,17,23 TETRA (TERT BUTYL) 25 [(3 PHENOXYACETYL)PENICILLOPROPYLOXY] 27 (3 NALIDIXOPROPYLOXY) 26,28 DIHYDROXYCALIX[4]ARENE; 5,11,17,23 TETRA (TERT BUTYL) 25,27 BIS(HYDROXYPROPYLOXY) 26,28 DIHYDROXYCALIX[4]ARENE; 5,11,17,23 TETRA (TERT BUTYL) 25,27 BIS[3 (PHENOXYACETYL)PENICILLOPROPYLOXY] 26,28 DIHYDROXYCALIX[4]ARENE; CALIXARENE; DIMETHYL SULFOXIDE; NALIDIXIC ACID; PENICILLIN V; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DISK DIFFUSION; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HYDROPHOBICITY; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CALIXARENES; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; PENICILLIN V; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 82255175456     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2011.10.031     Document Type: Article

References (52)

1. C.D. Gutsche Calixarenes J.F. Stoddart, Monographs in Supramolecular Chemistry Series 1989 Royal Society of Chemistry Cambridge
2. J. Vicens, and V. Böhmer Calixarenes A Versatile Class of Macrocyclic Compounds 1991 Kluwer Academic Publishers Dordrecht
3. C.D. Gutsche Calixarenes Revisited 1998 Royal Society of Chemistry Cambridge
4. Z. Asfari, V. Böhmer, J. Harrowfield, and J. Vicens Calixarenes 2001 2001 Kluwer Dordrecht The Netherlands
5. C. Wieser, D.B. Dieleman, and D. Matt Coord. Chem. Rev. 165 1997 93
6. R. Duncan Nat. Rev. Drug Disc. 2 2003 347 360
7. W.H. Mandeville, and D.I. Goldberg Curr. Pharm. Des. 3 1997 15
8. H. Ringsdorf J. Polym. Sci. Polym. Symp. 51 1975 35
9. R. Duncan, and J. Kopecek Adv. Polym. Sci. 57 1984 51
10. M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, and S. Inoue J. Controlled Release 11 1990 269
11. Y. Bae, S. Fukushima, A. Harada, and K. Kataoka Angew. Chem. 115 2003 4788
12. Angew. Chem. Int. Ed. 2003, 42, 4641
13. A. de Fatima, S.A. Fernandes, and A.A. Sabino Curr. Drug Discovery Technol. 6 2009 151
14. R.V. Rodik, V.I. Boyko, and V.I. Kalchenko Curr. Med. Chem. 16 2009 1630
15. Yo, T., Fujiwara; K., Otsuka, M., JP 10203906, 1998.
16. Hwang, K. M.; Qi, Y. M.; Liu, S. Y.; Choy, W.; Chen, J. WO Patent 9403164, 1994.
17. Harris, S. J. WO Patent 9519974, 1995.
18. Harris, S. J. WO Patent 0244121, 2002.
19. Coveney, D.; Costello, B. US 2005113454, 2005.
20. Kral, V.; Cigler, P.; Konvalinka, J.; Kozisek, M.; Prejdova, J.; Gruener, B.; Plesek, J.; Lepsik, M.; Pokorna, J.; Kraeusslich, H.-G.; Bodem, J. WO 2005073240, 2005.
21. R.P.M. Dings, X. Chen, D.M.E.I. Hellebrekers, L.I. van Eijk, Y. Zhang, T.R. Hoye, A.W. Griffioen, and K.H. Mayo J. Natl. Cancer Inst. 98 2006 932
22. A.E. Motornaya, L.M. Alimbarova, E.A. Shokova, and V.V. Kovalev Pharm. Chem. J. 40 2006 68
23. Hwang, K. M.; Qi, Y. M.; Liu, S. Y.; Lee, T. C.; Choy, W.; Chen, J. WO Patent 9403165, 1994.
24. Hulmes, D.; Coleman, A.; Aubert-Foucher, E. (CNRS, Fr) WO patent 0007585, 2000.
25. M. Dudic, A. Colombo, F. Sansone, A. Casnati, G. Donofrio, and R. Ungaro Tetrahedron 60 2004 11613
26. F. Sansone, M. Dudic, G. Donofrio, C. Rivetti, L. Baldini, A. Casnati, S. Cellai, and R. Ungaro J. Am. Chem. Soc. 128 2006 14528
27. V. Bagnacani, F. Sansone, G. Donofrio, L. Baldini, A. Casnati, and R. Ungaro Org. Lett. 10 2008 3953
28. J.W. Cornforth, P. D'Arcy Hart, G.A. Nicholls, R.J.W. Rees, and J.A. Stock Br. J. Pharmacology 10 1955 73
29. P. D'Arcy Hart, A.J. Armstrong, and E. Brodaty Infect. Immun. 64 1996 1491
30. M.J. Colston, H.C. Hailes, E. Stavropoulos, A.C. Herve, G. Herve, K.J. Goodworth, A.M. Hill, P. Jenner, P.D. Hart, and R.E. Tascon Infect. Immun. 72 2004 6318
31. F.A. Loiseau, A.M. Hill, and K.K. Hii Tetrahedron 63 2007 9947
32. A. Casnati, M. Fabbi, N. Pelizzi, A. Pochini, F. Sansone, and R. Ungaro Bioorg. Med. Chem. Lett. 6 1996 2699
33. M. Mourer, N. Psychogios, G. Laumond, A.-M. Aubertin, and J.-B. Regnouf-de-Vains Bioorg. Med. Chem. 18 2010 36
34. C. Geller, S. Fontanay, M. Mourer, H. Massimba Dibama, J.-B. Regnouf-de-Vains, C. Finance, and R.E. Duval Antivir. Res. 88 2010 343
35. M. Leeb Nature 431 2004 892
36. M. Mourer, R.E. Duval, C. Finance, and J.-B. Regnouf-de-Vains Bioorg. Med. Chem. Lett. 16 2006 2960
37. M. Grare, M. Mourer, J.-B. Regnouf-de-Vains, C. Finance, and R.E. Duval Pathol. Biol. 54 2006 470
38. M. Grare, M. Mourer, S. Fontanay, J.-B. Regnouf-de-Vains, C. Finance, and R.J. Duval J. Antimicrob. Chemother. 60 2007 575
39. M. Grare, E. Dague, M. Mourer, J.-B. Regnouf de Vains, C. Finance, J.F.L. Duval, R.E. Duval, and F. Gaboriaud Pathol. Biol. 55 2007 465
40. M. Mourer, H. Massimba Dibama, S. Fontanay, M. Grare, R.E. Duval, C. Finance, and J.-B. Regnouf-de-Vains Bioorg. Med. Chem. 17 2009 5496
41. M. Grare, S. Fontanay, H. Massimba Dibama, M. Mourer, J.-B. Regnouf-de-Vains, C. Finance, and R.E. Duval Pathol. Biol. 58 2010 46
42. M. Grare, H. Massimba Dibama, S. Lafosse, A. Ribon, M. Mourer, S. Fontanay, C. Finance, J.-B. Regnouf-de-Vains, and R.E. Duval Clin. Microbiol. Infec. 16 2010 432
43. A. Ben Salem, and J.-B. Regnouf-de-Vains Tetrahedron Lett. 42 2001 7033
44. A. Ben Salem, and J.-B. Regnouf-de-Vains Tetrahedron Lett. 44 2003 6769
45. B. Korchowiec, M. Orlof, G. Sautrey, A. Ben Salem, J. Korchowiec, J.B. Regnouf de Vains, and E. Rogalska J. Phys. Chem. B 114 2010 10427
46. B. Korchowiec, A. Ben Salem, Y. Corvis, J.B. Regnouf de Vains, J. Korchowiec, and E. Rogalska J. Phys. Chem. B 111 2007 13231
47. L.C. Groenen, B.H.M. Ruel, A. Casnati, W. Verboom, A. Pochini, R. Ungaro, and D.N. Reinhoudt Tetrahedron 47 1991 8379
48. Z.-T. Li, G.-Z. Ji, C.-X. Zhao, S.-D. Yuan, H. Ding, C. Huang, A.-L. Du, and M. Wei J. Org. Chem. 64 1999 3572
49. Fontanay, S.; Duval, R. E., unpublished results.
50. G.R. Freeman The Laryngoscope 86 1976 921 Chemical Abstract Number 1976219214
51. (a) Correa, W. M.; Correa, C.; Nogueira, M.; Langoni, H.; Carreira, E. L. C. Arquivos da Escola de Veterinaria da Universidade Federal de Minas Gerais 1981, 33(3), 449-453. Chemical Abstract Number 97:123785. (b) Kligman, Albert M. JAMA, the Journal of the American Medical Association (1965), 193(10;11), 796-804;923-8. AN 1965:483474. (c) Szydlowska, T. Zentralbl Bakteriol [Orig A] 239(2):270-4 (1977) AN 1978057374.
52. European Committee on Antimicrobial Susceptibility Testing. EUCAST disk diffusion test for routine antimicrobial susceptibility testing. EUCAST recommended strains for internal quality control (http://www.eucast.org/ fileadmin/src/media/PDFs/EUCAST-files/Disk-test-documents/EUCAST-QC-tables-1.3. pdf)